Relaxation therapy makes learning relaxation methods in positions and situations with a patient autonomy objective. It can set up an actual pain management program that reduces painful sensations and their consequences on the body. Relaxation therapy is recommended, for example, migraine, with whom she can recognize and avoid triggers, with the number of attacks and shorten their duration. Visit Relaxation Techniques To Control Chronic Pain
Pain can be frustrating and debilitating and can interfere with activities, time with family and friends, work, and sleep.
This covers a huge spectrum of conditions such as post-operative pain, sciatica, neuropathic pain, and others.The global chronic pain treatment market is predicted to grow at a 6.0% CAGR over the forecast period (2018-2023), as per the latest Market Research Future (MRFR) report.Various factors are propelling the chronic pain treatment market growth.
These factors, as stated by the MRFR report, include increasing technological advancements, rising prevalence of cancer pain, improved reimbursement policies, especially in developed countries, and improving regulatory framework.
Additional factors boosting market growth include increasing government assistance, rising competition between market players, unmet medical needs, and growing research funding.Avail FREE sample at: https://www.marketresearchfuture.com/sample_request/5975On the contrary, poor healthcare systems, lack of trained or skilled physicians, and high cost associated with technology in middle and low-income countries are factors that are likely to impede the chronic pain treatment market growth over the forecast period.Key PlayersLeading players profiled in the chronic pain treatment market report include –Teva PharmaceuticalsStryker CorporationSanofiPurdue Pharma LPNovartis AGMerck & Co. Inc.Nevro Corp.Dickinson and CompanyBectonNeurotech Na Inc.Braun Melsungen AGSmiths MedicalHalyard Health Inc.Pfizer Inc.Boston Scientific CorporationJude Medical Inc.Medtronic PLCMallinckrodt plcJohnson & Johnson Services Inc.GlaxoSmithKline plcForest LaboratoriesHoffmann-La Roche LtdEndo Health SolutionsEli Lilly & CompanyDJO Global LLCCodman And Shurtleff IncBayer AGAstraZeneca plcAstellas PharmaAllerganAbbvieAbbott LaboratoriesMarket SegmentationThe Market Research Future report provides a wide segmental analysis of the chronic pain treatment market based on end user, mode of purchase, indication, type of pain management drugs, and type of pain management devices.Based on pain management devices, the chronic pain treatment market is segmented inti ablation devices, analgesic infusion pumps, and neurostimulation devices.
Of these, the neurostimulation segment will have the largest share in the market over the forecast period.Based on the type of pain management drugs, the chronic pain treatment market is segmented into antidepressants, antimigraine agents, opioids, anesthetics, anticonvulsants, non-steroidal anti-inflammatory drugs (NSAIDS), and others.
The opioids segment is again segmented into methadone, meperidine, fentanyl, codeine, tramadol, hydrocodone, oxycodone, and others.Based on indication, the chronic pain treatment market is segmented into post-operative pain, migraine, arthritic pain, chronic back pain, fibromyalgia, musculoskeletal pain, facial pain, cancer pain, neuropathic pain, and others.
